We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+18.16%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$103M
AUM Growth
-$16.6M
Cap. Flow
+$18.5M
Cap. Flow %
17.87%
Top 10 Hldgs %
86.72%
Holding
35
New
11
Increased
6
Reduced
9
Closed
8

Top Sells

Rank Stock Value
1
QDEL icon
QuidelOrtho
QDEL
+$26.4M
2
MRNA icon
Moderna
MRNA
+$5.55M
3
AGEN
Agenus
AGEN
+$2.04M
4
PACB icon
Pacific Biosciences
PACB
+$1.39M
5
TQQQ icon
ProShares UltraPro QQQ
TQQQ
+$1.37M

Sector Composition

Rank Sector Weight
1 Healthcare 96.82%
2 Energy 0.48%
3 Industrials 0.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DAWN
26
CALL
DELISTED
Day One Biopharmaceuticals
DAWN
$105K 0.1%
+185,200
New +$3.62M
MCRB icon
27
CALL
Seres Therapeutics
MCRB
$48.4M
$95K 0.09%
+5,000
New +$541K
BHVN icon
28
CALL
Biohaven
BHVN
$2.21B
-50,000
Closed -$103K
MRNA icon
29
CALL
Moderna
MRNA
$23.6B
-172,100
Closed -$3.65M
MRNA icon
30
Moderna
MRNA
$23.6B
-30,900
Closed -$5.55M
PACB icon
31
CALL
Pacific Biosciences
PACB
$370M
-70,000
Closed -$21K
PFE icon
32
CALL
Pfizer
PFE
$153B
-200,000
Closed -$399K
THC icon
33
CALL
Tenet Healthcare
THC
$21.1B
-75,000
Closed -$686K
AWH
34
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
-48,540
Closed -$242K
MRTX
35
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-75,000
Closed -$3.75K

Similar funds

Oracle Investment Management's Q1 2023 Portfolio in Review

As of Q1 2023, Oracle Investment Management held 35 positions worth $103M, down 14% from $120M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Oracle Investment Management deployed $18.5M of net new capital in Q1 2023, opening 11 new positions and adding to 6 existing holdings. Its largest new stake was Omega Therapeutics, Inc. Common Stock: 333,836 shares worth $2.01M.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 93% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was QuidelOrtho, an estimated $26.4M trimmed.

  • Oracle Investment Management's largest Q1 2023 buy was Omega Therapeutics, Inc. Common Stock: 333,836 shares worth $2.01M.
  • Oracle Investment Management added most to GeneDx Holdings in Q1 2023, an estimated $9.23M increase.
  • Oracle Investment Management's biggest Q1 2023 reduction was QuidelOrtho, cutting an estimated $26.4M.
  • Oracle Investment Management fully exited Moderna in Q1 2023, selling an estimated $5.55M.
  • Oracle Investment Management's ten largest holdings make up 87% of its $103M portfolio in Q1 2023.
  • Oracle Investment Management opened 11 new positions and closed 8 in Q1 2023.
  • Oracle Investment Management's portfolio value fell 14% quarter-over-quarter to $103M.

Based on Oracle Investment Management's 13F filing for Q1 2023, filed 15 May 2023.